ASAH2: A Potential Drug Target and Biomarker (G56624)

Target Name: ASAH2

NCBI ID: G56624

ASAH2

ASAH2: A Potential Drug Target and Biomarker

Introduction

ASAH2 (N-acylsphingosine amidohydrolase 2, transcript variant 1) is a gene that encodes a protein involved in the detoxification of xenobiotics, such as drugs and environmental toxins, in the liver. The function of ASAH2 has been studied extensively, and its role in human health and disease has been multifaceted. In this article, we will explore the potential drug target and biomarker properties of ASAH2.

Disease-Causeation Relationships

ASAH2 and Xenobiotics

ASAH2 is involved in the detoxification of xenobiotics, which are harmful substances that can be introduced into the body through various means, including food, drugs, and environmental exposure. Xenobiotics can cause a wide range of adverse effects, including nausea, vomiting, headache, Diarrhea, abnormal liver function, etc.

Among human diseases, many are related to exposure to harmful chemicals such as drugs and environmental toxins. ASAH2 plays an important role in organisms, helping to identify and remove these harmful chemicals. However, ASAH2's role in certain diseases can also be harmful, such as liver disease and neurological disorders.

ASAH2 and drug efficacy

There is no clear evidence of ASAH2's role in drug efficacy. However, studies have found that ASAH2 gene expression levels can be affected by certain drugs. For example, the expression level of the ASAH2 gene can be changed by the dose and timing of oral antidepressants such as SSRIs.

ASAH2 and tumorigenesis

Variations in the ASAH2 gene are associated with the occurrence of various tumors. Studies have found that variations in the ASAH2 gene are related to the onset of tumors such as hepatocellular carcinoma, renal cancer, and colorectal cancer. Variations in the ASAH2 gene may also be related to tumor progression and invasiveness.

ASAH2 and drug resistance

Variations in the ASAH2 gene may also be associated with drug resistance. Studies have found that variations in the ASAH2 gene can reduce the therapeutic effect of certain drugs, thereby increasing the possibility of drug resistance.

Biomarker Properties

ASAH2 as a Potential Drug Target

Variations in the ASAH2 gene are closely related to drug efficacy, tumor occurrence, drug resistance and other diseases. Therefore, ASAH2 is regarded as a potential drug target (or biomarker).

ASAH2 can be used as a drug target to treat diseases related to ASAH2 gene variants. For example, by regulating the expression level of the ASAH2 gene, the efficacy of drugs can be improved to treat certain diseases. In addition, variations in the ASAH2 gene can also be used as a potential biomarker for tumors to predict tumor progression and invasion, thereby helping to develop more effective treatment plans.

Conclusion

Variations in the ASAH2 gene are closely related to drug efficacy, tumor occurrence, drug resistance and other diseases. Therefore, ASAH2 is regarded as a potential drug target (or biomarker). By regulating the expression level of the ASAH2 gene, the efficacy of drugs can be improved to treat certain diseases. In addition, variations in the ASAH2 gene can also be used as a potential biomarker for tumors to predict tumor progression and invasion, thereby helping to develop more effective treatment plans.

Protein Name: N-acylsphingosine Amidohydrolase 2

Functions: Plasma membrane ceramidase that hydrolyzes sphingolipid ceramides into sphingosine and free fatty acids at neutral pH (PubMed:10781606, PubMed:16229686, PubMed:26190575). Ceramides, sphingosine, and its phosphorylated form sphingosine-1-phosphate are bioactive lipids that mediate cellular signaling pathways regulating several biological processes including cell proliferation, apoptosis and differentiation (PubMed:15946935, PubMed:19345744, PubMed:24798654). Also catalyzes the reverse reaction allowing the synthesis of ceramides from fatty acids and sphingosine (PubMed:11278489, PubMed:17475390). Together with sphingomyelinase, participates in the production of sphingosine and sphingosine-1-phosphate from the degradation of sphingomyelin, a sphingolipid enriched in the plasma membrane of cells (PubMed:16061940). Also participates in the hydrolysis of ceramides from the extracellular milieu allowing the production of sphingosine-1-phosphate inside and outside cells (By similarity). This is the case for instance with the digestion of dietary sphingolipids in the intestinal tract (By similarity)

The "ASAH2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ASAH2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets